Atlas Trials

Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis

Clinical trial NCT06863701 · RECRUITING

Trial details

NCT number
NCT06863701
Sponsor
Laboratorios Silanes S.A. de C.V.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Gout ArthritisGout Attack
Start date
2025-01-27
Primary completion
2026-12-31
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.